Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity

BJU International

Volumn 93, Issue 1, 2004, Pages 89-92

  Hindley, R G ^a,b   Brierly, R D ^a   Thomas, P J ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b c/o Craig End ^*  (United Kingdom)

Author keywords

Bethanechol chloride; Detrusor; Hypocontractility; Prostaglandin E2; Underactivity; Urodynamics

Indexed keywords

BETHANECHOL; PLACEBO; PROSTAGLANDIN E2; CHOLINERGIC RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; BLADDER EMPTYING; CATHETERIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETRUSOR MUSCLE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MUSCLE CONTRACTILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TABLET; URINE VOLUME; BLADDER DISEASE; DRUG COMBINATION; DRUG POTENTIATION; MIDDLE AGED; QUALITY OF LIFE; TREATMENT OUTCOME; URINE RETENTION; URODYNAMICS;

ADULT; AGED; AGED, 80 AND OVER; BETHANECHOL; DINOPROSTONE; DOUBLE-BLIND METHOD; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARASYMPATHOMIMETICS; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME; URINARY BLADDER DISEASES; URINARY RETENTION; URODYNAMICS;

EID: 1542434946     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.04563.x     Document Type: Article

References (14)

1. Light JK, Scott FB. Bethanechol chloride and the traumatic cord bladder. J Urol 1982; 128: 85
2. Awad S. Clinical use of bethanechol. J Urol 1985; 134: 523-4
3. Barrett D. M. The effect of oral bethanechol chloride on voiding in female patients with excessive residual: a randomised double-blind study. J Urol 1980; 126: 640
4. Wein AJ, Malloy TR, Shofer F, Raezer DM. The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine Volumes. J Urol 1980; 124: 397-9
5. Sonda LP, Gershon C, Diokno AC, Lapides J. Further observations on the cystometric and uroflowmetric effects of bethanechol chloride on the human bladder. J Urol 1979; 122: 775-7
6. Delaere KPJ, Thomas CMG, Moonen WA, Debruyne FMJ. The value of intravesical prostaglandin E2 and F2-alpha in women with abnormalities of bladder emptying. Br J Urol 1981; 53: 306-9
7. Bergman A, Mushkat Y, Gordon D, David MP. Prostaglandins for enhancing bladder function after vaginal surgery. J Repro Med 1992; 37: 320-2
8. Wagner G, Husslein P, Enzelberger H. Is prostaglandin E2 really of therapeutic value for postoperative urinary retention? Results of a prospectively randomized double-blind study. Am J Obstet Gynecol 1985; 151: 375-9
9. Desmond AD, Bultitude MI, Hills NH, Shuttleworth KE. Clinical experience with intravesical prostaglandin E2. A prospective study of 36 patients. Br J Urol 1980; 52: 357-66
10. Abrams P, Blaivas JG, Stanton SL, Andersen J. T. The Standardisation of Terminology of Lower Urinary Tract Function. Scand J Urol Nephrol Suppl 1988; 114: 5-18
11. Finkbeiner AE. Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review. J Urol 1985; 134: 443-9
12. Matzkin H, van-der-Zwaag R, Chen Y et al. How reliable is a single measurement of urinary flow in the diagnosis of obstruction in benign prostatic hyperplasia? Br J Urol 1993; 72: 181-6
13. Dunsmuir WD, Feneley M, Corry DA, Bryan J, Kirby RS. The day-to-day variation (test-retest reliability) of residual urine measurement. Br J Urol 1996; 77: 192-3
14. George NJ, O'Reilly PH, Barnard RJ, Blacklock NJ. High pressure chronic retention. Br Med J 1983; 286: 1780-3